CRSP Crispr Therapeutics AG

USD 46.29 -0.97 ( -2.05)%
Icon

Crispr Therapeutics AG (CRSP) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 46.29

-0.97 (-2.05)%

USD 4.03B

2.09M

USD 77.60(+67.64%)

USD 94.83 (+104.86%)

Icon

CRSP

Crispr Therapeutics AG (USD)
COMMON STOCK | NSD
USD 46.29
-0.97 ( -2.05)%

Crispr Therapeutics AG (CRSP) Stock Forecast

Show ratings and price targets of :
USD 77.60
(+67.64%)

Based on the Crispr Therapeutics AG stock forecast from 11 analysts, the average analyst target price for Crispr Therapeutics AG is USD 77.60 over the next 12 months. Crispr Therapeutics AG’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Crispr Therapeutics AG is Bullish , which is based on 8 positive signals and 3 negative signals. At the last closing, Crispr Therapeutics AG’s stock price was USD 46.29. Crispr Therapeutics AG’s stock price has changed by -1.20% over the past week, -4.58% over the past month and -31.49% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...